Weber and colleagues generated autologous T-cell lines from ALL patients by targeting the tumor-associated antigens WT1, MAGE-A3, Survivin, and PRAME [13], which were able to specifically kill autologous leukemia blasts in vitro. This evidence concerns the gene WT1 and leukemia.